Key Operational Developments Announcements, page-7

Taken from BOD facebook page.

Bod, the only Australian company participating in the project, is helping provide reliable pharmaceutical-grade medicinal cannabis to patients in need.

The registry will help provide access to patients with:
- Anxiety Disorder
- Chronic Pain
- Multiple Sclerosis (MS)
- Post-Traumatic Stress Disorder (PTSD)
- Substance Use Disorder (as a harm reduction strategy)
- Tourette’s Syndrome

We believe that the findings of Project Twenty21 will build evidence on the benefits of medicinal cannabis, which will lower the cost of medication and ultimately help support doctors and patients.